Health Care: Drugs

Sanofi (SNY: NYSE)

$45.98 0.6 | 1.32%
12/17/14 - 04:03 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 45.99B 47.55B 45.44B 42.61B
Cost of Sales 11.51B 12.57B 11.23B 10.04B
Gross Operating Profit 34.48B 34.99B 34.21B 32.56B
Selling, General, and Administrative Expenses 12.21B 12.43B 11.47B 10.43B
Research & Development 6.59B 6.51B 6.24B 5.85B
Operating Income before D & A (EBITDA) 15.68B 16.04B 16.50B 16.28B
Depreciation & Amortization 7.69B 6.49B 7.20B 6.82B
Interest Income 150.52M 122.99M 181.45M 139.65M
Other Income - Net 1.00B 1.26B 1.40B 1.59B
Special Income / Charges -1.48B -408.65M -184.05M 0.00
Total Income Before Interest Expenses (EBIT) 7.25B 9.02B 9.00B 9.37B
Interest Expense 845.09M 731.35M 715.44M 621.09M
Pre-Tax Income 6.40B 8.29B 8.28B 8.75B
Income Taxes 1.05B 1.50B 589.72M 1.65B
Minority Interest 218.18M 223.50M 312.36M 337.81M
Net Income From Continuing Operations 5.35B 6.79B 7.69B 7.10B
Net Income From Discontinued Operations 0.00 0.00 0.00 513.37M
Net Income From Total Operations 5.35B 6.79B 7.69B 7.61B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 5.13B 6.57B 7.38B 7.27B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
7.25B 8.71B 9.58B 8.92B
Preferred Dividends
Net Income Available To Common 5.35B 6.79B 7.69B 7.10B
Basic EPS from Continuing Ops. 1.94 2.49 2.79 2.59
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.20
Basic EPS from Total Operations 1.94 2.49 2.79 2.79
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.94 2.49 2.79 2.79
Basic Normalized Net Income/Share 2.63 3.19 3.48 3.25
EPS fr Continuing Ops. 1.92 2.47 2.78 2.58
EPS fr Discontinued Ops 0.00 0.00 0.00 0.20
EPS fr Total Ops. 1.92 2.47 2.78 2.78
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.92 2.47 2.78 2.78
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.60 3.17 3.46 3.25
Dividends Paid per Share 1.30 1.69 1.32 1.10

Portfolios with SNY

Latest SNY Headlines from TheStreet

More Financial News for SNY

Press Releases for SNY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter